Right Ventricular Contractility Predicts Clearance of Ascites After Transjugular Intrahepatic Portosystemic Shunt [0.03%]
右心室收缩性预测经颈静脉肝内门体分流术后腹水吸收情况
Lukas A Heger,Johannes Chang,Charlotte Rohrer et al.
Lukas A Heger et al.
Background and aims: Implantation of transjugular intrahepatic portosystemic shunt (TIPS) is an important treatment in patients with decompensated cirrhosis. The impact of right ventricular dysfunction on clinical outcome...
scRNA-Seq Reveals Sustained Pro-Inflammation by Innate Immune Activation in In Utero HBV-Exposed Neonates of High HBsAg Mothers [0.03%]
单细胞 RNA 测序揭示了高 HBsAg 阳性母亲的宫内乙型肝炎病毒暴露婴儿先天免疫激活导致的持续促炎症反应
Prabhjyoti Pahwa,Ravinder Singh,Partha Chattopadhyay et al.
Prabhjyoti Pahwa et al.
Background and aim: High levels of HBV DNA and HBsAg titres increase the risk of mother-to-child transmission. Development of adaptive immunity post HBV vaccination in neonates born to HBsAg-positive mothers may be determ...
Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-on-Chronic Liver Failure [0.03%]
特利压林治疗急性-on-慢性肝功能衰竭早期患者肝肾综合征的效果
Don C Rockey,Fredric Gordon,Paul J Thuluvath et al.
Don C Rockey et al.
Background & aims: Hepatorenal syndrome-acute kidney injury (HRS-AKI) is a life-threatening complication of decompensated cirrhosis. The US Food and Drug Administration approved terlipressin use for HRS-AKI based on the C...
Comment on Armisen et al.: Methodological Considerations for MPO Inhibition Trials in MASH [0.03%]
关于Armisen等人的评论：MASH中MPO抑制试验的方法学考虑因素
Baodong Wang,Jiayuan Huang,Zhiyun Chen
Baodong Wang
Tregs With High CD29 Expression Promote Cell Adhesion and Contribute to the Malignant Transformation of MASLD [0.03%]
高CD29表达的调节性T细胞促进细胞黏附并参与MASLD恶性转化
Yuming Lu,Luyin Liu,Mengya Zhou et al.
Yuming Lu et al.
Background and aim: Regulatory T cells (Tregs) are highly enriched in the metabolic dysfunction-associated steatotic liver disease (MASLD) microenvironment, but their role in driving metabolic dysfunction-associated steat...
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries [0.03%]
六国糖尿病患者代谢紊乱相关脂肪肝疾病筛查的成本估算
Jeffrey V Lazarus,Leire Agirre-Garrido,J Emilio Miralles-Sanchez et al.
Jeffrey V Lazarus et al.
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are highly prevalent among people living with type 2...
Evaluating the Long-Term Benefits of Medications for Alcohol Use Disorder in Alcohol-Associated Cirrhosis [0.03%]
评估治疗酒精性肝硬化的酒精使用障碍的长期利益研究
Chengu Niu,Jing Zhang,Daniel-Jose Idoate-Domench et al.
Chengu Niu et al.
Background and aims: The effectiveness and safety of medications for alcohol use disorder (MAUD) in treating alcohol-associated cirrhosis have not been fully elucidated. This study aims to explore the clinical benefits an...
Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD [0.03%]
基于脉冲染料密度测定的吲哚青绿清除试验在儿童肝纤维化诊断中的应用研究
Miaoxia Liu,Xiaofeng Zhang,Xiao Cheng et al.
Miaoxia Liu et al.
Background and aims: Performance of pulse dye densitometry (PDD)-estimated indocyanine green 15-min retention rate (ICG-R15) in the diagnosis of clinically significant portal hypertension (CSPH) has not been studied. A pr...